266
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Self nanoemulsifying granules (SNEGs) of meloxicam: preparation, characterization, molecular modeling and evaluation of in vivo anti-inflammatory activity

, , &
Pages 600-610 | Received 14 Apr 2016, Accepted 17 Dec 2016, Published online: 17 Jan 2017

References

  • Turesson C, O'Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722–7.
  • Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med 2007;120:936–9.
  • Luger P, Daneck K, Engel W, Trummlitz G. Structure and physicochemical properties of Meloxicam, a new NSAID. Eur J Pharm Sci 1996;4:175–87.
  • Pignatello R, Ferro M, De Guidi G, et al. Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100® and RL100®. Int J Pharm 2001;218:27–42.
  • Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev 1999;36:125–41.
  • Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173–82.
  • Date AA, Desai N. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond) 2010;5:1595–616.
  • Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev 2007;59:667–76.
  • Mcclements DJ. Nanoemulsions versus microemulsions: terminology, differences and similarities. Soft Matter 2012;8:1719–29.
  • Anton N, Vandamme TF. Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm Res 2011;28:978–85.
  • Singh B, Bandopadhay S, Kapil R, et al. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Therc Drug Carrier Syst 2009;26:427–521.
  • Dokania S, Joshi AK. Self-microemulsifying drug delivery system (SMEDDS)-challenges and road ahead. Drug Deliv 2015;22:675–90.
  • Biradar SV, Dhumal RS, Paradkar AR. Rheological investigation of self-emulsification process: effect of co-surfactant. J Pharm Pharmaceut Sci 2009;12:164–74.
  • Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today 2008;13:606–12.
  • Baka E, Comer JE, Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 2008;46:335–41.
  • Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharmaceut 2007;329:166–72.
  • Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm 2008;355:269–76.
  • Kang BK, Lee JS, Chon SK, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65–73.
  • Schrödinger Suite 2012. New York, NY: Schrödinger, LLC; 2012.
  • Huang YB, Tsai YH, Yang WC, et al. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur J Pharm Biopharm 2004;58:607–14.
  • Holm R, Jensen IH, Sonnergaard J. Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev Ind Pharm 2006;32:1025–32.
  • Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol 2003;225:115–21.
  • Brooks RR, Carpenter JF, Jones SM, et al. Canine carrageenan-induced acute paw inflammation model and its response to non-steroidal anti-inflammatory drugs. J Pharmacol Methods 1991;25:275–83.
  • Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci 2000;11:S93–8.
  • Gershanik T, Benita S. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. Pharm Dev Technol 1996;1:147–57.
  • Peira E, Carlotti ME, Trotta C, et al. Positively charged microemulsions for topical application. Int J Pharm 2008;346:119–23.
  • Hagigit T, Nassar T, Behar-Cohen F, et al. The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsions. Eur J Pharm Biopharm 2008;70:248–59.
  • Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour. Int J Pharm 2000;198:7–27.
  • Huang YB, Tsai YH, Lee SH, et al. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm 2005;289:87–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.